Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT05735730
NA

Can the Risk for AMD be Modulated?

Sponsor: Association for Innovation and Biomedical Research on Light and Image

View on ClinicalTrials.gov

Summary

The goal of this Cross-sectional, interventional study is to learn about whether different risk factors, as Mediterranean diet, lifestyle and concomitant medication can modulate the risk imprinted by genetics in Age-related macular degeneration (AMD). The main question it aims to answer is: How the genetic risk interacts with environmental and lifestyle factors, especially Mediterranean diet and chronic medication, in order to assess how this interplay protects or presents higher risk for the establishment or the progression of AMD. Participants: Vital Signs will be measured; Medical History, Demographics, Nutritional/lifestyle habits and Family History of AMD will be recorded; Ophthalmological Examination will be performed Genetic analysis will be performed.

Official title: Diet, Lifestyle, Systemic Medication and Genetics: Can the Risk for AMD be Modulated?

Key Details

Gender

All

Age Range

55 Years - Any

Study Type

INTERVENTIONAL

Enrollment

1800

Start Date

2023-06-26

Completion Date

2028-01-12

Last Updated

2025-09-23

Healthy Volunteers

No

Interventions

OTHER

Blood draw

The study intervention consists of a blood draw for genetic analysis.

Locations (1)

AIBILI-CEC (AIBILI- Clinical Trials Centre)

Coimbra, Portugal